Award
National Institute of Allergy and Infectious Diseases 4R01AI169296-04
Lipid mediated oral tolerance
Recipient
State University of New York at Buffalo
Award Amount
$931,012.00
Ceiling
$931,012.00
Awarded
June 09, 2025
Identifier
4R01AI169296-04
Award for research on lipid nanoparticle-based immunotherapy to induce oral tolerance for autoimmune diseases and allergies.
Description
The project focuses on developing an immunotherapy platform using lipid nanoparticles to induce oral tolerance and treat autoimmune conditions, allergies, and reduce immunogenicity of therapeutic proteins. The research involves biophysical, cellular, and molecular studies, including in vivo, ex vivo, and in vitro experiments.